Audiological involvement in patients with systemic sclerosis

Audiological involvement in patients with systemic sclerosis

OBJECTIVESThe aim of the present study was to evaluate hearing loss in patients diagnosed with systemic sclerosis (SSc) and to investigate the relation between hearing loss, subtypes of the disease, its duration and clinical findings, and antibody positivity. METHODSThe study included 47 patients wi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Modern rheumatology 2022-10, Vol.32 (6), p.1094-1101
Hauptverfasser: Turan, Kubra, Yayla, Mucteba Enes, Arslan, Murat, Tokgoz Yilmaz, Suna, Okatan, Ercan, Turgay, Murat, Meco, Cem
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1101
container_issue 6
container_start_page 1094
container_title Modern rheumatology
container_volume 32
creator Turan, Kubra
Yayla, Mucteba Enes
Arslan, Murat
Tokgoz Yilmaz, Suna
Okatan, Ercan
Turgay, Murat
Meco, Cem
description OBJECTIVESThe aim of the present study was to evaluate hearing loss in patients diagnosed with systemic sclerosis (SSc) and to investigate the relation between hearing loss, subtypes of the disease, its duration and clinical findings, and antibody positivity. METHODSThe study included 47 patients with SSc and 44 healthy controls. Audiometric, tympanometric, and otoacoustic emission measurements were applied to both groups. RESULTSThe evaluation of the participants medical history showed that among the patients with SSc, 19.1% experienced ear fullness, 27.7% experienced vertigo, and 36.2% experienced tinnitus. Hearing loss was detected in 23.4% of the patients with SSc. The corresponding result was 4.3% in the control group with a statistically significant difference (p = 0.001). Transient-evoked otoacoustic emission amplitude values were significantly lower in the patients' both ears with SSc than the control group (p 
doi_str_mv 10.1093/mr/roab107
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2605230532</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2605230532</sourcerecordid><originalsourceid>FETCH-LOGICAL-c288t-326cbc13362e82f344c99942078e2a66a5551b677e57cc49d103aec692f8f2833</originalsourceid><addsrcrecordid>eNo1kM1KAzEYRYMoWKsbn2CWIozNzySTgJtS_IOCG12HTPqNRjKTmm-m0rd3pHV1z-JyuRxCrhm9Y9SIRZcXObmG0fqEzFglTFkrak7_WRp5Ti4QvygV0mgzI_fLcRNSTB_Bu1iEfpfiDjroh4mLrRvChFj8hOGzwD0O0AVfoI-QEwa8JGetiwhXx5yT98eHt9VzuX59elkt16XnWg-l4Mo3ngmhOGjeiqryxpiK01oDd0o5KSVrVF2DrL2vzIZR4cArw1vdci3EnNwcdrc5fY-Ag-0CeojR9ZBGtFxRyQWVgk_V20PVTw8xQ2u3OXQu7y2j9k-R7bI9KhK_ArhaYA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2605230532</pqid></control><display><type>article</type><title>Audiological involvement in patients with systemic sclerosis</title><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Turan, Kubra ; Yayla, Mucteba Enes ; Arslan, Murat ; Tokgoz Yilmaz, Suna ; Okatan, Ercan ; Turgay, Murat ; Meco, Cem</creator><creatorcontrib>Turan, Kubra ; Yayla, Mucteba Enes ; Arslan, Murat ; Tokgoz Yilmaz, Suna ; Okatan, Ercan ; Turgay, Murat ; Meco, Cem</creatorcontrib><description>OBJECTIVESThe aim of the present study was to evaluate hearing loss in patients diagnosed with systemic sclerosis (SSc) and to investigate the relation between hearing loss, subtypes of the disease, its duration and clinical findings, and antibody positivity. METHODSThe study included 47 patients with SSc and 44 healthy controls. Audiometric, tympanometric, and otoacoustic emission measurements were applied to both groups. RESULTSThe evaluation of the participants medical history showed that among the patients with SSc, 19.1% experienced ear fullness, 27.7% experienced vertigo, and 36.2% experienced tinnitus. Hearing loss was detected in 23.4% of the patients with SSc. The corresponding result was 4.3% in the control group with a statistically significant difference (p = 0.001). Transient-evoked otoacoustic emission amplitude values were significantly lower in the patients' both ears with SSc than the control group (p &lt; 0.005). Duration of disease was significantly longer, and diffusing capacity of the lungs for carbon monoxide values were significantly higher in the patients with SSc and sensorineural hearing loss. CONCLUSIONSThe present study found that the incidence of hearing loss was significantly higher in the study group than in the healthy control group. In addition to other organ involvements, cochlear involvement occurs in these patients, and further studies are required.</description><identifier>ISSN: 1439-7595</identifier><identifier>EISSN: 1439-7609</identifier><identifier>DOI: 10.1093/mr/roab107</identifier><language>eng</language><ispartof>Modern rheumatology, 2022-10, Vol.32 (6), p.1094-1101</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c288t-326cbc13362e82f344c99942078e2a66a5551b677e57cc49d103aec692f8f2833</citedby><cites>FETCH-LOGICAL-c288t-326cbc13362e82f344c99942078e2a66a5551b677e57cc49d103aec692f8f2833</cites><orcidid>0000-0003-0744-7481</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Turan, Kubra</creatorcontrib><creatorcontrib>Yayla, Mucteba Enes</creatorcontrib><creatorcontrib>Arslan, Murat</creatorcontrib><creatorcontrib>Tokgoz Yilmaz, Suna</creatorcontrib><creatorcontrib>Okatan, Ercan</creatorcontrib><creatorcontrib>Turgay, Murat</creatorcontrib><creatorcontrib>Meco, Cem</creatorcontrib><title>Audiological involvement in patients with systemic sclerosis</title><title>Modern rheumatology</title><description>OBJECTIVESThe aim of the present study was to evaluate hearing loss in patients diagnosed with systemic sclerosis (SSc) and to investigate the relation between hearing loss, subtypes of the disease, its duration and clinical findings, and antibody positivity. METHODSThe study included 47 patients with SSc and 44 healthy controls. Audiometric, tympanometric, and otoacoustic emission measurements were applied to both groups. RESULTSThe evaluation of the participants medical history showed that among the patients with SSc, 19.1% experienced ear fullness, 27.7% experienced vertigo, and 36.2% experienced tinnitus. Hearing loss was detected in 23.4% of the patients with SSc. The corresponding result was 4.3% in the control group with a statistically significant difference (p = 0.001). Transient-evoked otoacoustic emission amplitude values were significantly lower in the patients' both ears with SSc than the control group (p &lt; 0.005). Duration of disease was significantly longer, and diffusing capacity of the lungs for carbon monoxide values were significantly higher in the patients with SSc and sensorineural hearing loss. CONCLUSIONSThe present study found that the incidence of hearing loss was significantly higher in the study group than in the healthy control group. In addition to other organ involvements, cochlear involvement occurs in these patients, and further studies are required.</description><issn>1439-7595</issn><issn>1439-7609</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNo1kM1KAzEYRYMoWKsbn2CWIozNzySTgJtS_IOCG12HTPqNRjKTmm-m0rd3pHV1z-JyuRxCrhm9Y9SIRZcXObmG0fqEzFglTFkrak7_WRp5Ti4QvygV0mgzI_fLcRNSTB_Bu1iEfpfiDjroh4mLrRvChFj8hOGzwD0O0AVfoI-QEwa8JGetiwhXx5yT98eHt9VzuX59elkt16XnWg-l4Mo3ngmhOGjeiqryxpiK01oDd0o5KSVrVF2DrL2vzIZR4cArw1vdci3EnNwcdrc5fY-Ag-0CeojR9ZBGtFxRyQWVgk_V20PVTw8xQ2u3OXQu7y2j9k-R7bI9KhK_ArhaYA</recordid><startdate>20221015</startdate><enddate>20221015</enddate><creator>Turan, Kubra</creator><creator>Yayla, Mucteba Enes</creator><creator>Arslan, Murat</creator><creator>Tokgoz Yilmaz, Suna</creator><creator>Okatan, Ercan</creator><creator>Turgay, Murat</creator><creator>Meco, Cem</creator><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-0744-7481</orcidid></search><sort><creationdate>20221015</creationdate><title>Audiological involvement in patients with systemic sclerosis</title><author>Turan, Kubra ; Yayla, Mucteba Enes ; Arslan, Murat ; Tokgoz Yilmaz, Suna ; Okatan, Ercan ; Turgay, Murat ; Meco, Cem</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c288t-326cbc13362e82f344c99942078e2a66a5551b677e57cc49d103aec692f8f2833</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Turan, Kubra</creatorcontrib><creatorcontrib>Yayla, Mucteba Enes</creatorcontrib><creatorcontrib>Arslan, Murat</creatorcontrib><creatorcontrib>Tokgoz Yilmaz, Suna</creatorcontrib><creatorcontrib>Okatan, Ercan</creatorcontrib><creatorcontrib>Turgay, Murat</creatorcontrib><creatorcontrib>Meco, Cem</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Modern rheumatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Turan, Kubra</au><au>Yayla, Mucteba Enes</au><au>Arslan, Murat</au><au>Tokgoz Yilmaz, Suna</au><au>Okatan, Ercan</au><au>Turgay, Murat</au><au>Meco, Cem</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Audiological involvement in patients with systemic sclerosis</atitle><jtitle>Modern rheumatology</jtitle><date>2022-10-15</date><risdate>2022</risdate><volume>32</volume><issue>6</issue><spage>1094</spage><epage>1101</epage><pages>1094-1101</pages><issn>1439-7595</issn><eissn>1439-7609</eissn><abstract>OBJECTIVESThe aim of the present study was to evaluate hearing loss in patients diagnosed with systemic sclerosis (SSc) and to investigate the relation between hearing loss, subtypes of the disease, its duration and clinical findings, and antibody positivity. METHODSThe study included 47 patients with SSc and 44 healthy controls. Audiometric, tympanometric, and otoacoustic emission measurements were applied to both groups. RESULTSThe evaluation of the participants medical history showed that among the patients with SSc, 19.1% experienced ear fullness, 27.7% experienced vertigo, and 36.2% experienced tinnitus. Hearing loss was detected in 23.4% of the patients with SSc. The corresponding result was 4.3% in the control group with a statistically significant difference (p = 0.001). Transient-evoked otoacoustic emission amplitude values were significantly lower in the patients' both ears with SSc than the control group (p &lt; 0.005). Duration of disease was significantly longer, and diffusing capacity of the lungs for carbon monoxide values were significantly higher in the patients with SSc and sensorineural hearing loss. CONCLUSIONSThe present study found that the incidence of hearing loss was significantly higher in the study group than in the healthy control group. In addition to other organ involvements, cochlear involvement occurs in these patients, and further studies are required.</abstract><doi>10.1093/mr/roab107</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-0744-7481</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1439-7595
ispartof Modern rheumatology, 2022-10, Vol.32 (6), p.1094-1101
issn 1439-7595
1439-7609
language eng
recordid cdi_proquest_miscellaneous_2605230532
source Oxford University Press Journals All Titles (1996-Current)
title Audiological involvement in patients with systemic sclerosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T01%3A39%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Audiological%20involvement%20in%20patients%20with%20systemic%20sclerosis&rft.jtitle=Modern%20rheumatology&rft.au=Turan,%20Kubra&rft.date=2022-10-15&rft.volume=32&rft.issue=6&rft.spage=1094&rft.epage=1101&rft.pages=1094-1101&rft.issn=1439-7595&rft.eissn=1439-7609&rft_id=info:doi/10.1093/mr/roab107&rft_dat=%3Cproquest_cross%3E2605230532%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2605230532&rft_id=info:pmid/&rfr_iscdi=true